About This Article
In addition to its role in the pathogenesis of migraine, calcitonin gene-related peptide (CGRP) is implicated in the regulation of insulin secretion. However, there are limited data on the use of CGRP inhibitor monoclonal antibodies in individuals who are overweight/obese and those with diabetes.
![Tolerability of eptinezumab in overweight, obese or type 1 diabetes patients. thumbnail](https://prosciento.com/wp-content/uploads/2022/01/journal-5.png)